quinuclidines has been researched along with donepezil in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dawson, GR; Iversen, SD | 1 |
| Anderson, DJ; Bitner, RS; Browman, K; Buccafusco, J; Bunnelle, WH; Decker, MW; Drescher, KU; Gopalakrishnan, M; Kohlhaas, KL; Markosyan, S; Marsh, KC; Nikkel, AL; Radek, R | 1 |
| Bertrand, D; Bertrand, S; Boess, FG; Chesworth, R; Flood, DG; Gawryl, M; Hilt, D; König, G; Methfessel, C; Prickaerts, J; Reneerkens, OA; Shapiro, G; van Goethem, NP | 1 |
| Flood, DG; Jeggo, R; Koenig, G; Leventhal, L; Patzke, H; Townsend, M; van den Top, M; Walczak, JS; Whyment, A | 1 |
| Berry, S; Gault, LM; Lenz, RA; Meier, A; Othman, AA; Pritchett, Y; Ritchie, CW; Robieson, WZ; Tang, Q | 1 |
| Benitex, Y; Bookbinder, M; Bristow, LJ; Keavy, D; King, D; Macor, JE; Morgan, DG; Olson, R; Polino, J; Signor, L; Weed, MR; Zaczek, R | 1 |
1 trial(s) available for quinuclidines and donepezil
| Article | Year |
|---|---|
ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Cholinergic Agonists; Cholinesterase Inhibitors; Cognition Disorders; Donepezil; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Indans; Male; Mental Status Schedule; Middle Aged; Piperidines; Quinuclidines; Thiadiazoles; Treatment Outcome | 2016 |
5 other study(ies) available for quinuclidines and donepezil
| Article | Year |
|---|---|
The effects of novel cholinesterase inhibitors and selective muscarinic receptor agonists in tests of reference and working memory.
Topics: Animals; Avoidance Learning; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cholinesterase Inhibitors; Conditioning, Classical; Discrimination Learning; Donepezil; Dose-Response Relationship, Drug; Indans; Learning; Memory; Mice; Oxadiazoles; Pain Threshold; Parasympathomimetics; Physostigmine; Piperidines; Pyrazines; Quinuclidines; Rats; Receptors, Muscarinic; Thiophenes | 1993 |
In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease.
Topics: Acetylcholine; alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Avoidance Learning; Behavior, Animal; Cognition; Cyclic AMP Response Element-Binding Protein; Donepezil; Electroencephalography; Extracellular Signal-Regulated MAP Kinases; Glycogen Synthase Kinase 3; Indans; Indoles; Macaca mulatta; Male; Mice; Mice, Knockout; Nicotinic Agonists; Nootropic Agents; Phosphorylation; Piperidines; Psychomotor Performance; Quinuclidines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Recognition, Psychology; Social Perception; tau Proteins | 2010 |
EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Brain; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Drug Partial Agonism; Indans; Male; Memory; Nicotinic Agonists; Piperidines; Quinuclidines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Nicotinic; Thiophenes | 2012 |
α7-nAChR agonist enhances neural plasticity in the hippocampus via a GABAergic circuit.
Topics: Action Potentials; alpha7 Nicotinic Acetylcholine Receptor; Animals; Cholinesterase Inhibitors; Donepezil; Evoked Potentials; Excitatory Amino Acid Antagonists; Female; GABA Agents; GABAergic Neurons; Hippocampus; Humans; Indans; Inhibitory Postsynaptic Potentials; Male; Nerve Net; Nicotinic Agonists; Oocytes; Piperidines; Quinuclidines; Rats; Rats, Sprague-Dawley; Thiophenes; Xenopus laevis | 2016 |
Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Donepezil; Indans; Macaca fascicularis; Male; Paired-Associate Learning; Piperidines; Quinuclidines; Reaction Time; Scopolamine; Space Perception; Spiro Compounds; Task Performance and Analysis; Thiophenes; Treatment Outcome; Visual Perception | 2017 |